Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma

Abstract

The MPI, consisting of pretreatment inflammatory markers, NLR, platelet count, and CRP, might be effective in predicting the survival of newly diagnosed MM patients undergoing active treatment.